Humira launch date?

Humira (adalimumab) was first approved and launched in the United States in 2002.

• FDA approval date: 19 June 2002 for rheumatoid arthritis.
• Commercial launch: Shortly after approval—late 2002, with the first commercial sales starting in the latter part of that year.

AbbVie (the company that now owns Humira) rolled out the product in other major markets (e.g., the EU, Canada, and the UK) in the following months and early 2003.